Although the exact Alzheimer’s trigger is unknown, it is established that activity of certain enzymes does play a role in the onset and development of the disease. The researchers targeted ADAM10 by administering an oral drug commonly used for psoriasis to Alzheimer’s patients. The drug led to elevated levels of the nerve cell-protecting growth factor APPs-alpha in their spinal fluid. This stimulates the activity of ADAM10, which reduces the buildup of amyloid plaques commonly seen in Alzheimer’s disease. ADAM10 has been shown to improve memory and enhance learning capability.
The medication was well tolerated among the patients. A larger clinical study is needed to establish the drug’s impact on Alzheimer’s disease patients and to determine its long-term effect.
Treatment options for Alzheimer’s disease
Treatment options for Alzheimer’s disease involve lifestyle and medical interventions. There are medications available for Alzheimer’s disease, and although they do not cure the disease they could slow down its progression and lessen disease severity. Some other treatment options for Alzheimer’s disease include:
- Taking medications as recommended by the doctor
- Reducing stress and anxiety
- Keeping up with a regular daily routine to minimize memory problems
- Using calendars, diaries, memos, and reminders
- Keeping the mind active with puzzles or learning something new
- Taking time to relax
- Getting proper sleep
- Staying social and keeping a strong social network
- Visiting a memory support group
It’s also encouraged that Alzheimer’s patients maintain a healthy lifestyle as best as possible. Although there isn’t much evidence that eating well and exercising may drastically improve Alzheimer’s disease, these habits could help maintain good health, thus minimizing the risk of additional complications that could worsen Alzheimer’s disease.
Sources:
http://www.uni-mainz.de/presse/17845_ENG_HTML.php